← Current compounder rows

Current NDC auxiliary source row compounder:4288

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source
ndc_compounder_zip
Product Ndc Raw
83556-0101
Product Ndc
83556-0101
Product Ndc Digits
835560101
Product Type Name
HUMAN COMPOUNDED DRUG
Proprietary Name
Avastin 1.25mg/0.05mL
Proprietary Name Suffix
[empty]
Nonproprietary Name
Repackaged Avastin 1.25mg/0.05mL
Dosage Form Name
INJECTION, SOLUTION
Route Name
INTRAOCULAR
Marketing Category Name
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name
Turbare Manufacturing
Establishment Name
Turbare Manufacturing
Establishment Fei
[empty]
Substance Name
BEVACIZUMAB
Active Ingredients Info
1.25 mg/.05 mL
History Active Ingredients Raw
BEVACIZUMAB
History Active Ingredients Info Raw
1.25 mg/.05 mL
History Dosage Raw
INJECTION, SOLUTION
Dea Schedule
[empty]
Package Ndc Raw
83556-0101-1
Package Ndc
83556-0101-1
Package Ndc Digits
8355601011
Package Ndc11
83556010101
Package Description
.07 mL in 1 SYRINGE, PLASTIC (83556-0101-1)
Reporting Period Raw
2026-1
Reporting Period
2026-1
Normalization Status
valid
Source Url
https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive
compounders_ndc_directory.zip
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Last Modified
Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256
222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256
f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id
compounder:4288
Source Row Number
4288
Source Row Hash
1b9231679c44619bda6a308e1eabfa7ba756c5021f4a3deefb365027577f7a54
Import Run Id
20261116T204628Z
Loaded At
2026-11-16 20:58:00

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAOCULAR",
    "PRODUCTNDC": "83556-0101",
    "DEASCHEDULE": "",
    "LABELERNAME": "Turbare Manufacturing",
    "SUBSTANCENAME": "BEVACIZUMAB",
    "DOSAGEFORMNAME": "INJECTION, SOLUTION",
    "NDCPACKAGECODE": "83556-0101-1",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Avastin 1.25mg/0.05mL",
    "REPORTINGPERIOD": "2026-1",
    "NONPROPRIETARYNAME": "Repackaged Avastin 1.25mg/0.05mL",
    "PACKAGEDESCRIPTION": ".07 mL in 1 SYRINGE, PLASTIC (83556-0101-1) ",
    "ACTIVEINGREDIENTSINFO": "1.25 mg/.05 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset
compounder
Record Source
ndc_compounder_zip
Source Record Id
compounder:4288
Source Row Number
4288
Status Scope
package
Lookup Ndc
83556-0101-1
Lookup Ndc Digits
8355601011
Product Ndc
83556-0101
Product Ndc Digits
835560101
Package Ndc
83556-0101-1
Package Ndc Digits
8355601011
Package Ndc11
83556010101
Product Id
[empty]
Status Code
COMPOUNDER
Status Label
Outsourcing facility compounded drug report
Reporting Period Raw
2026-1
Reporting Period
2026-1
Source Table
fda_ndc_aux_compounder
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Row Hash
1b9231679c44619bda6a308e1eabfa7ba756c5021f4a3deefb365027577f7a54
Import Run Id
20261116T204628Z
Loaded At
2026-11-16 20:58:00